Gene · 6550
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications. | Viruses | 2023 | 37376531 | PubTator, text mining | PubMed |
| Multifaceted Roles of GLP-1 and Its Analogs: A Review on Molecular Mechanisms with a Cardiotherapeutic Perspective. | Pharmaceuticals (Basel) | 2023 | 37375783 | PubTator, text mining | PubMed |
| Novel Drugs for the Management of Diabetes Kidney Transplant Patients: A Literature Review. | Life (Basel) | 2023 | 37374048 | PubTator, text mining | PubMed |
| Renal Oxygen Demand and Nephron Function: Is Glucose a Friend or Foe? | Int J Mol Sci | 2023 | 37373108 | PubTator, text mining | PubMed |
| Increased intestinal permeability and downregulation of absorptive ion transporters Nhe3, Dra, and Sglt1 contribute to diarrhea during Clostridioides difficile infection. | Gut Microbes | 2023 | 37350393 | PubTator, text mining | PubMed |
| Novelties in the pharmacological approaches for chronic heart failure: new drugs and cardiovascular targets. | Front Cardiovasc Med | 2023 | 37332581 | PubTator, text mining | PubMed |
| High dietary K+ intake inhibits proximal tubule transport. | Am J Physiol Renal Physiol | 2023 | 37318989 | PubTator, text mining | PubMed |
| Impact of sodium-glucose co-transporter 2 inhibitors on renal outcomes in patients of diabetes mellitus: A meta-analysis of landmark renal and cardiovascular outcome trials. | Indian J Pharmacol | 2023 | 37313937 | PubTator, text mining | PubMed |
| Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection. | Am J Prev Cardiol | 2023 | 37313358 | PubTator, text mining | PubMed |
| Tenapanor in the Treatment of Irritable Bowel Syndrome with Constipation: Discovery, Efficacy, and Role in Management. | Clin Exp Gastroenterol | 2023 | 37309470 | PubTator, text mining | PubMed |
| Non-Haemodynamic Mechanisms Underlying Hypertension-Associated Damage in Target Kidney Components. | Int J Mol Sci | 2023 | 37298378 | PubTator, text mining | PubMed |
| Intracellular Angiotensin II Stimulation of Sodium Transporter Expression in Proximal Tubule Cells via AT1 (AT1a) Receptor-Mediated, MAP Kinases ERK1/2- and NF-кB-Dependent Signaling Pathways. | Cells | 2023 | 37296613 | PubTator, text mining | PubMed |
| Kidney and blood pressure regulation-latest evidence for molecular mechanisms. | Clin Kidney J | 2023 | 37261007 | PubTator, text mining | PubMed |
| Effect of pregnancy and hypertension on kidney function in female rats: Modeling and functional implications. | PLoS One | 2023 | 37253048 | PubTator, text mining | PubMed |
| SGLT-2 Inhibitors and the Inflammasome: What's Next in the 21st Century? | Nutrients | 2023 | 37242177 | PubTator, text mining | PubMed |
| Nephroprotective Properties of Antidiabetic Drugs. | J Clin Med | 2023 | 37240483 | PubTator, text mining | PubMed |
| SGLT2 Inhibitors: A New Therapeutical Strategy to Improve Clinical Outcomes in Patients with Chronic Kidney Diseases. | Int J Mol Sci | 2023 | 37240080 | PubTator, text mining | PubMed |
| Cardiorenal syndrome and diabetes: an evil pairing. | Front Cardiovasc Med | 2023 | 37234376 | PubTator, text mining | PubMed |
| SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA. | Nephrol Dial Transplant | 2023 | 37230946 | PubTator, text mining | PubMed |
| Proteomic analysis of urinary extracellular vesicles highlights specific signatures for patients with primary aldosteronism. | Front Endocrinol (Lausanne) | 2023 | 37223008 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6550/papers?page=12